Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01716884
  4. Details
NCT01716884 Clinical Trial

China STEMI-PCI Program

ST Segment Elevation Myocardial Infarction Clinical Trial

Official title:
China STEMI-PCI Program

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT01716884
Other study ID # 2011[436]
Secondary ID
Status Recruiting
Phase N/A
First received October 26, 2012
Last updated October 26, 2012
Start date December 2011
Est. completion date June 2016

Study information
Verified date October 2012
Source Peking University First Hospital
Contact Yan Zhang, MD
Phone 8610-83575180
Email drzhy1108@163.com
Is FDA regulated No
Health authority China: Ministry of Health
Study type Observational

Clinical Trial Summary

1. Registration

2. Performing in three stages

3. Major aim: Much more and standard reperfusion therapy in STEMI patients

Recruitment information / eligibility
Status Recruiting
Enrollment 4000
Est. completion date June 2016
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Onset of STEMI within 12h

- Onset of STEMI within 12-36h needing primary PCI

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
China Division of Cardiology, Peking University First Hospital Beijing

Sponsors (3)
Lead Sponsor Collaborator
Peking University First Hospital Abbott Vascular, Sanofi

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary The reperfusion ratio up to 1 day No
Secondary Door to Balloon time up to 1 day No
Secondary BMS ratio up to 1 day No
Secondary health economic evaluation up to 1 year No
See also
  Status Clinical Trial Phase
Recruiting NCT02869906 - Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Non Culprit Lesions in Patients With ST-segment Elevation Myocardial Infarction N/A
Not yet recruiting NCT03895983 - ST Segment Resolution After Primary Percutaneous Coronary Intervention.
Not yet recruiting NCT03252665 - Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI Phase 4
Completed NCT02026219 - Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction Phase 4
Completed NCT03247738 - Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI Phase 4
Recruiting NCT05461781 - Distal Transradial Access for Primary PCI in STEMI Patients to Prevent RAO N/A
Recruiting NCT03561389 - iFR-guided Revascularization in STEMI
Completed NCT01538303 - Microvascular Dysfunction in Acute Myocardial Infarction (AMI) and Its Relation to Outcome
Recruiting NCT02979236 - Italian Multi-center Registry of Self-apposing Coronary Stent in Patients With STEMI N/A
Completed NCT05705089 - Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI Phase 3
Completed NCT01897350 - Myocardial Oedema in ST Segment Elevation Myocardial Infarction Myocardial N/A
Not yet recruiting NCT03753269 - Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction Phase 4
Completed NCT03234348 - MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction Phase 3
Recruiting NCT03406832 - Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI N/A
Recruiting NCT03406819 - Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI N/A
Recruiting NCT03508232 - Doxycycline to Protect Heart Muscle After Heart Attacks Phase 2
Recruiting NCT04220736 - Early Prediction of QFR in STEMI-Pharmaco-invasice
Completed NCT03780335 - Early Prediction of QFR in STEMI-I
Recruiting NCT03787745 - Ischemic Postconditioning in STEMI Patients Treated With Primary PCI N/A
Recruiting NCT03621111 - A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction N/A